Clinical Trial

A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adults

Completed Phase 1
View on ClinicalTrials.gov →
Summary
A study to learn how the study medicine called Ibuzatrelvir is taken up into the blood in healthy Chinese adults.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-14; most recent amendment 2026-01-05.
Status change: Active, Not Recruiting → Completed 2025-12-18
Trial Details
NCT Number NCT07235137
Lead Sponsor Pfizer
Conditions Healthy Participant
Enrollment 12 participants
Start Date 2025-10-16
Primary Completion 2025-11-21 (estimated)
Study Completion 2025-11-21 (estimated)
Updated on ClinicalTrials.gov 2026-01-07